SpaceOAR Vue™ Hydrogel

Radiopaque Perirectal Spacer for Radiation Therapy

Deliver Care with Confidence

Perirectal spacers are recommended as a pre-treatment option within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)*

Perirectal spacers are recommended as a
pre-treatment option within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)*

Download Clinical Summary >

graphic of iodine dose
Graphic with chart

Minimal Risk

Iodinated contrast media reactions occur in less than 1% of the population, with few or no symptoms.1,2

Icon of Microscope on purple field

Enhanced Visibility

SpaceOAR Vue Hydrogel delivers similar clinical benefits as SpaceOAR Hydrogel, plus enhanced CT visibility3


Access SpaceOAR Hydrogel Evidence

doctors at computer
  1. Mammarappallil JG, Hiatt KD, Vincent W, et al. How accurate is the label “allergic to iodinated contrast agents”? Acta Radiol. 2016 Jan;57(1):47-50.
  2. Cha MJ, Kang DY, Lee W, et al. Hypersensitivity reactions to iodinated contrast media: A multicenter study of 196 081 patients. Radiology. 2019 Oct;293(1):117-24
  3. Data on file with Boston Scientific

*Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer V.2.2020 © National Comprehensive Cancer Network, Inc. 2020. All rights reserved. Accessed July 8, 2020. To view the most recent and complete version of the guideline, go to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.

Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum.

As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Top